Actively Recruiting

Phase Not Applicable
Age: 19Years +
FEMALE
NCT06923306

Virtual Reality Exposure for Vaginismus: A Replicated Single-Case Design

Led by University of British Columbia · Updated on 2025-09-25

20

Participants Needed

2

Research Sites

95 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

C

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Vaginismus is a sexual dysfunction characterized by involuntary tightening of the pelvic floor muscles, preventing vaginal intercourse. It is defined by an intense fear of vaginal penetration, leading to persistent difficulties with vaginal intercourse and gynaecological exams. Psychological factors play a significant role in vaginismus. If the pelvic floor muscle tightening represents a defensive reflex, then treatment using a gradual exposure to feared stimuli using virtual reality may lead to an extinction of the phobic response, and to amelioration of vaginismus. If effective, the use of virtual reality technology can directly improve clinical care offered to those suffering from vaginismus.

CONDITIONS

Official Title

Virtual Reality Exposure for Vaginismus: A Replicated Single-Case Design

Who Can Participate

Age: 19Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals who have a vagina, including cisgender women, transgender women with gender-affirming surgery, and transgender men without bottom surgery
  • Diagnosis of vaginismus with self-reported involuntary vaginal muscle tightness causing persistent interference with vaginal penetration lasting more than 6 months
  • Age over 19 years
  • Any sexual orientation
  • Fluent in English to understand psychoeducational materials and questionnaires
  • Normal or corrected-to-normal vision to view VR scenes
  • Able to travel to Vancouver for study participation
Not Eligible

You will not qualify if you...

  • Presence of unprovoked vaginal pain
  • Having a vulvar skin condition such as lichen sclerosus
  • Having an imperforate hymen
  • Epilepsy characterized by photosensitive seizures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

UBC Sexual Health Lab, Vancouver Hospital

Vancouver, British Columbia, Canada, V5M 1M9

Actively Recruiting

2

Diamond Health Care Centre

Vancouver, British Columbia, Canada, V5Z1M9

Actively Recruiting

Loading map...

Research Team

L

Lauren Selden

CONTACT

K

Kelsey Lynch, MA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here